SR One srone.com

SR One - Key People

Name Bio Twitter
Jill CarrollJill joined SR One in 2011 with a background in biotech partnering and commercial development. Prior to SR One, Jill was responsible for Corporate Development at Dynavax Technologies, where she was involved in multiple pharma partnering deals as well show more…
Rajeev DadooRajeev joined SR One in 2003 and is an alum of the Kauffman Fellows Program. Rajeev has been involved with SR Ones investments in Cydex, Hypnion, iPierian, Inc., Predix Pharmaceuticals, Rib-X Pharmaceuticals, Octoplus, Trigen, Nucleonics, and Pinnac show more…
Jens EcksteinRajeev joined SR One in 2003 and is an alum of the Kauffman Fellows Program. Rajeev has been involved with SR Ones investments in Cydex, Hypnion, iPierian, Inc., Predix Pharmaceuticals, Rib-X Pharmaceuticals, Octoplus, Trigen, Nucleonics, and Pinnac show more…
Matthew FoyMatthew joined SR One in 2011 to take the lead in investing SR One's UK biotech fund. Prior to joining SR One he worked as a consultant for Longbow Capital Partners in London. Before that he was a Vice President of Greenhill & Co, an M&A Investment B show more…
Brian GallagherBrian established the SR One Boston office in 2010 and is focused on building innovative therapeutic and life science companies. He previously led the firm's investments in Dicerna Pharmaceuticals (NASDAQ: DRNA) and SpringLeaf Therapeutics. He has ov show more…
See all 10 people